{"nct_id":"NCT05291689","title":"A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2022-05-24","start_date_type":"ACTUAL","primary_completion_date":"2023-10-18","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}